TP-102 clinical study will be presented on the Bacteriophage Therapy Summit 2021

Technophage will be presenting the first information on the recently initiated TP-102 clinical study at the Bacteriophage Therapy Summit 2021 – Digital Event tomorrow, March 24, at 2:45pm EDT. The talk entitled Going into REVERSE: Assessing the Safety of Bacteriophage Treatment in the Management of Diabetic Foot Infections will be given by Dr. Ran Nir-Paz, Principal Investigator of the study, and Associate Professor at the Hadassah-Hebrew University Medical Center. Learn more about it at Bacteriophage Therapy Summit 2021.

The release as fetched from its publisher. technophage.pt ↗